Literature DB >> 19885352

Combining insulin pumps and continuous glucose monitors; where are we to go from here?

J Hans DeVries1.   

Abstract

Insulin pump development started in 1978, with the first commercially available glucose sensor marketed in 1999. Combining these two instruments is a logical step toward the closed loop. This article discusses three questions: Is pump development complete? How can a pump and a sensor be combined? Can the delay problem associated with the subcutaneous-subcutaneous approach for the closed loop be overcome?

Entities:  

Keywords:  artificial pancreas; closed loop; continuous glucose monitoring; continuous subcutaneous insulin infusion; insulin pump therapy

Year:  2008        PMID： 19885352      PMCID： PMC2771492          DOI： 10.1177/193229680800200215

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


  6 in total

1.  The use of insulin pumps with meal bolus alarms in children with type 1 diabetes to improve glycemic control.

Authors:  H Peter Chase; Brian Horner; Kim McFann; Hannah Yetzer; Jana Gaston; Carolyn Banion; Rosanna Fiallo-Scharer; Robert Slover; Georgeanna Klingensmith
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

2.  Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Authors:  Dorothee Deiss; Jan Bolinder; Jean-Pierre Riveline; Tadej Battelino; Emanuele Bosi; Nadia Tubiana-Rufi; David Kerr; Moshe Phillip
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

3.  Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited.

Authors:  Iris M E Wentholt; Augustus A M Hart; Joost B L Hoekstra; J Hans Devries
Journal:  Diabetes Technol Ther       Date:  2007-04       Impact factor: 6.118

4.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.

Authors:  John Pickup; Martin Mattock; Sally Kerry
Journal:  BMJ       Date:  2002-03-23

5.  Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c.

Authors:  Ravi Retnakaran; Jackie Hochman; J Hans DeVries; Helene Hanaire-Broutin; Robert J Heine; Vincent Melki; Bernard Zinman
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

6.  Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.

Authors:  Andreas Pfützner; Alfred E Mann; Solomon S Steiner
Journal:  Diabetes Technol Ther       Date:  2002       Impact factor: 6.118
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.